Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.19B | 2.18B | 2.24B | 2.58B | 1.62B | 976.59M |
Gross Profit | 472.81M | 474.06M | 466.10M | 556.75M | 372.91M | 187.81M |
EBITDA | 165.08M | 169.82M | 161.86M | 343.35M | 184.79M | 90.02M |
Net Income | 39.93M | 46.48M | 36.05M | 128.67M | 103.14M | 28.03M |
Balance Sheet | ||||||
Total Assets | 1.47B | 1.40B | 1.23B | 1.43B | 1.11B | 459.52M |
Cash, Cash Equivalents and Short-Term Investments | 24.43M | 33.74M | 13.00M | 65.07M | 7.76M | 457.98K |
Total Debt | 673.53M | 623.07M | 564.03M | 789.86M | 570.59M | 166.61M |
Total Liabilities | 839.89M | 763.08M | 705.25M | 922.00M | 700.89M | 220.06M |
Stockholders Equity | 633.78M | 634.57M | 526.87M | 506.97M | 414.03M | 239.46M |
Cash Flow | ||||||
Free Cash Flow | 93.13M | 133.54M | 226.30M | 199.88M | -72.88M | 61.75M |
Operating Cash Flow | 103.28M | 142.75M | 238.08M | 210.69M | -65.42M | 64.19M |
Investing Cash Flow | -159.07M | -147.46M | -13.48M | -279.47M | -306.63M | ― |
Financing Cash Flow | 59.80M | 30.00M | -285.99M | 128.61M | 378.85M | ― |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | C$857.03M | 11.54 | 11.99% | 5.79% | 23.84% | 17.05% | |
73 Outperform | C$494.39M | 13.80 | 6.93% | 6.13% | 2.19% | -48.80% | |
73 Outperform | C$699.79M | 6.93 | 12.00% | 4.47% | 4.99% | 38.70% | |
72 Outperform | C$850.91M | 13.92 | 7.08% | 1.72% | 6.80% | -6.80% | |
67 Neutral | $2.28B | 14.12 | 9.90% | 4.16% | 5.82% | -15.76% | |
61 Neutral | C$1.29B | 50.65 | 2.78% | 3.77% | 20.53% | 74.96% | |
61 Neutral | C$7.19B | -4.76 | -4.20% | 2.32% | 13.56% | -31.48% |
ADENTRA reported strong financial results for the second quarter of 2025, with sales reaching $597.1 million, an 8.7% increase from the previous year. The company achieved a slight increase in gross margin and a significant rise in adjusted EBITDA, reflecting successful operational execution and the positive impact of its acquisition of Woolf Distributing. Despite a challenging construction market, ADENTRA effectively managed its capital, reducing debt and returning $11.2 million to shareholders through dividends and share repurchases. Looking ahead, the company plans to focus on cash generation and reducing leverage, while remaining vigilant about potential tariff impacts on its product mix.
The most recent analyst rating on (TSE:ADEN) stock is a Buy with a C$49.00 price target. To see the full list of analyst forecasts on ADENTRA stock, see the TSE:ADEN Stock Forecast page.
ADENTRA Inc. has announced it will release its second quarter 2025 financial results on August 6, 2025, after market close. The following day, a conference call will be held by CEO Rob Brown and CFO Faiz Karmally to discuss the company’s financial performance, providing stakeholders with insights into ADENTRA’s operational and market positioning.
The most recent analyst rating on (TSE:ADEN) stock is a Buy with a C$51.00 price target. To see the full list of analyst forecasts on ADENTRA stock, see the TSE:ADEN Stock Forecast page.